Entering text into the input field will update the search result below

Repare Therapeutics GAAP EPS of -$0.70 beats by $0.02, revenue of $6.88M beats by $3.6M

Mar. 01, 2022 4:54 PM ETRepare Therapeutics Inc. (RPTX)By: Gaurav Batavia, SA News Editor
  • Repare Therapeutics press release (NASDAQ:RPTX): Q4 GAAP EPS of -$0.70 beats by $0.02.
  • Revenue of $6.88M (+4814.3% Y/Y) beats by $3.6M.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About RPTX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Repare Therapeutics Inc.
Vanda Pharmaceuticals Inc.
AEON Biopharma, Inc.
Ovid Therapeutics Inc.
Mesoblast Limited
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.